Atossa Therapeutics
ATOS
ATOS
86 hedge funds and large institutions have $41.6M invested in Atossa Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.89% more ownership
Funds ownership: 20.85% → 21.74% (+0.89%)
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
Holders
86
Holding in Top 10
–
Calls
$1M
Puts
$169K
Top Buyers
| 1 | +$1.04M | |
| 2 | +$715K | |
| 3 | +$223K | |
| 4 |
Barclays
London,
United Kingdom
|
+$188K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$171K |
Top Sellers
| 1 | -$366K | |
| 2 | -$187K | |
| 3 | -$164K | |
| 4 |
Two Sigma Investments
New York
|
-$132K |
| 5 |
Mariner
Overland Park,
Kansas
|
-$126K |